GlassScriptPhysician profile
Zubaria Sarooj
NPI 1871873265
$2,106.68
in general payments reported to CMS, 2019-2025
18 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2020: $204 · 2021: $662 · 2022: $424 · 2023: $278 · 2024: $47.29 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sebela Pharmaceuticals INC. | $569.96 | 2019-2023 | Naftin |
| Paratek Pharmaceuticals, INC. | $445.93 | 2021-2025 | Nuzyra |
| Smith+Nephew, INC. | $260.20 | 2019-2025 | Grafix Pl, Collagenase Santyl |
| Horizon Therapeutics Plc | $213.02 | 2021-2023 | Krystexxa |
| Merck Sharp & Dohme LLC | $112.85 | 2019 | |
| Orthofix Medical, INC. | $79.96 | 2024-2025 | Physio-Stim |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $75.87 | 2021 | |
| Nabriva Therapeutics, Plc | $64.29 | 2021-2022 | |
| Bioventus LLC | $51.36 | 2019-2021 | |
| Melinta Therapeutics, LLC | $42.79 | 2019 | |
| Stryker Corporation | $38.59 | 2019 | |
| Tactile Systems Technology INC | $33.97 | 2020-2021 | |
| Medtronic, INC. | $29.87 | 2023 | Venaseal |
| Alfasigma USA, INC. | $20.87 | 2021 | |
| Fidia Pharma USA INC. | $19.25 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $16.43 | 2023 | Puraply |
| Grt US Holding, INC. | $16.17 | 2021 | |
| Heron Therapeutics, INC. | $15.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zubaria Sarooj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.